Posted on 26/07/2010 in Scientific Beckman Coulter has experienced a 19.2 per cent year-on-year increase in second quarter revenue in what it described as challenging market conditions.
The biomedical testing specialist's revenue total for the period came to $902 million (582.1 million pounds), a large percentage of which was attributable to its recent acquisition of Olympus Diagnostics.
It noted that this was achieved in spite of the ongoing softness of demand in the life science and cellular business sectors, which has impacted negatively on business in other areas.
The company's chairman, president and chief executive officer Scott Garrett stated that results had met expectations, predicting growth in the coming months.
He said: "Beckman Coulter has a strong installed base of customers, an enviable new product pipeline and a 75-year history of meeting the needs of customers."
The company enjoyed what it described as a "solid" year in 2009, with revenue increasing by 22 per cent for the 12 months compared to 2008. Other news stories from 26/07/2010
Read more in the Zenopa News Archive
How this news is generated
|
